News

The FDA approval is based on the results of different studies evaluating Remicade in adults with ulcerative colitis plus additional data from a Phase 3 trial investigating the

Faslodex is an oestrogen receptor antagonist, which can bind, block and degrade the oestrogen receptor, thereby helping in the treatment of hormone receptor-positive metastatic breast cancer which has

The study , which was conducted between 2004 and 2009, evaluated the efficiency of isolated soy protein consumption on the progression of atherosclerosis. The double-blind, placebo-controlled parallel-design study

Single-tablet regimen, Eviplera, combines Gilead’s Truvada (emtricitabine and tenofovir disoproxil (as fumarate)) with Tibotec Pharmaceuticals’ non-nucleoside reverse transcriptase inhibitor Edurant (rilpivirine (as hydrochloride)). The submission of the application

The patent protects Invisicare in three main areas: its composition, its method of combining polymers to make the Invisicare complex and the skin / medical conditions Invisicare is

The Phase 1 dose-ranging study expects to investigate ACY-1215 alone and in conjunction with bortezomib (Velcade) and dexamethasone. Following identification of optimal combination dosing in Phase 1, the

Fibroblast Growth Factor 21 (FGF-21) protein is indicated for use in treating type 2 diabetes, and the Relaxin hormone, for treating heart failure. The agreement enables Ambrx to

The company’s Rivastigmine Tartrate Capsules are the generic version of Novartis’ Exelon Capsules. Exelon is a cholinesterase inhibitor which helps in treating mild to moderate dementia in patients

The lawsuit alleges that under an agreement signed with Watson Pharmaceuticals, Amphastar has given right to market, sell and distribute Enoxaparin Sodium Injection in the US, infringing Momenta’s